Univariable and multivariable logistic regression analysis of the effect of PCI treatment—DES excluding BVS versus BMS (reference)—on event rates (claims data of the German local healthcare funds in 2008–2014)
| Adjusted OR* (95% CI) | Crude OR (95% CI) | |
| Mortality during index hospitalisation | 0.70 (0.61 to 0.80) | 0.59 (0.53 to 0.66) |
| MACCE (1 year) | 0.72 (0.70 to 0.75) | 0.63 (0.61 to 0.65) |
| Of these: mortality (1 year) | 0.70 (0.67 to 0.74) | 0.58 (0.55 to 0.61) |
| CABG after index hospitalisation (1 year) | 0.69 (0.63 to 0.75) | 0.70 (0.65 to 0.76) |
| Of these: within 30 days | 0.60 (0.47 to 0.76) | 0.68 (0.54 to 0.87) |
| Of these: within 31–365 days | 0.70 (0.64 to 0.77) | 0.70 (0.65 to 0.77) |
| PCI after index hospitalisation (1 year) | 0.99 (0.94 to 1.04) | 1.11 (1.04 to 1.15) |
| Of these: within 90 days | 1.14 (1.07 to 1.21) | 1.27 (1.20 to 1.35) |
| Of these: within 91–365 days | 0.87 (0.81 to 0.93) | 0.90 (0.84 to 0.96) |
| Coronary angiography after index hospitalisation (1 year) | 1.14 (1.06 to 1.23) | 1.16 (1.09 to 1.25) |
*Risk adjustment included age, sex, comorbidities according to the Elixhauser classification, shock, New York Heart Association class (I versus II, III or IV), left main CAD, multivessel disease (two or three vessels), number of PCI (one coronary artery versus a minimum of two) at index hospitalisation, AMI and dialysis in the year preceding admission and year of treatment.
BMS, bare metal stent; BVS, bio-resorbable vascular scaffold; CABG, coronary artery bypass graft; DES, drug-eluting stent; MACCE, major cerebrovascular and cardiovascular event; PCI, percutaneous coronary intervention.